Galpha(q) and Gbetagamma Regulate PAR-1 Signaling of Thrombin-induced NF-kappaB Activation and ICAM-1 Transcription in Endothelial Cells
Overview
Authors
Affiliations
As thrombin binding to the G protein-coupled proteinase activated receptor-1 (PAR-1) induces endothelial adhesivity to leukocytes through NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression, we determined the signaling pathways mediating the response. Studies showed that the heterotrimeric G proteins, Galpha(q), and the Gbetagamma dimer were key determinants of the PAR-1 agonist peptide (TFLLRNPNDK)-induced NF-kappaB activation and ICAM-1 expression in endothelial cells. Cotransfection of RGS3T, a regulator of G-protein signaling that inhibits Galpha(q), or alpha-transducin (Galpha(t)), a scavenger of the Gbetagamma, markedly decreased NF-kappaB activity induced by PAR-1 activation. We determined the downstream signaling targets activated by Galpha(q) and Gbetagamma that mediate NF-kappaB activation. Expression of the kinase-defective protein kinase C (PKC)-delta mutant inhibited NF-kappaB activation induced by the constitutively active Galpha(q) mutant, but had no effect on NF-kappaB activity induced by Gbeta(1)gamma(2). In related experiments, NF-kappaB as well as ICAM-1 promoter activation induced by Gbeta(1)gamma(2) were inhibited by the expression of the dominant-negative mutant of 85-kDa regulatory subunit of PI 3-kinase; however, the expression of this mutant had no effect on the response induced by activated Galpha(q). Cotransfection of the catalytically inactive Akt mutant inhibited the NF-kappaB activation induced by the constitutively active PI 3-kinase mutant as well as that by the activated forms of Galpha(q) and PKC-delta. These results support a model in which ligation of PAR-1 induces NF-kappaB activation and ICAM-1 transcription by the engagement of parallel Galphaq/PKC-delta and Gbetagamma/PI3-kinase pathways that converge at Akt.
Nag N, Ray T, Tapader R, Gope A, Das R, Mahapatra E iScience. 2024; 27(6):109828.
PMID: 38799586 PMC: 11126781. DOI: 10.1016/j.isci.2024.109828.
Ma L, Willey J Thromb Update. 2024; 8:100117.
PMID: 38620713 PMC: 9270234. DOI: 10.1016/j.tru.2022.100117.
Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in mice.
Grover S, Bharathi V, Posma J, Griffin J, Palumbo J, Mackman N Blood Adv. 2022; 7(10):1945-1953.
PMID: 36477178 PMC: 10189413. DOI: 10.1182/bloodadvances.2022008637.
Therapeutic Targeting of NF-κB in Acute Lung Injury: A Double-Edged Sword.
Millar M, Fazal F, Rahman A Cells. 2022; 11(20).
PMID: 36291185 PMC: 9601210. DOI: 10.3390/cells11203317.
Bourget C, Adams K, Morshead C J Neuroinflammation. 2022; 19(1):146.
PMID: 35705953 PMC: 9199194. DOI: 10.1186/s12974-022-02487-x.